Kopran Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹153.99 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 34.20 per cent from ₹234.02 crore. This corresponds to a year-on-year *(YoY) growth of 13.88 per cent.
Operating Profit
Operating Profit stands at ₹15.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 52.05 per cent from ₹32.95 crore. This corresponds to a year-on-year *(YoY) growth of 11.82 per cent.
PBDT
PBDT stands at ₹14.57 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 51.22 per cent from ₹29.87 crore. This corresponds to a year-on-year *(YoY) growth of 2.97 per cent.
Profit Before Tax
Profit Before Tax stands at ₹8.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 65.29 per cent from ₹25.35 crore. This corresponds to a year-on-year *(YoY) decline of 11.02 per cent.
Net Profit
Net Profit stands at ₹6.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 64.49 per cent from ₹18.87 crore. This represents a 10.07 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Kopran Ltd Earnings
- YOY
- QOQ
Kopran Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Kopran Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Kopran Ltd Financial Reports
Kopran Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Kopran | -1.30% | -4.82% | -5.62% | -1.65% | 44.90% | 21.99% |
| Bajaj Healthcare | 1.02% | -0.97% | 0.91% | 5.47% | -1.97% | -25.32% |
| Bharat Parenter. | 2.36% | 13.52% | -0.67% | 16.29% | 33.04% | 13.64% |
| Wanbury | -2.19% | -1.31% | -20.32% | -12.50% | -0.85% | -6.07% |
| Anlon Healthcare | 0.13% | 5.29% | -4.00% | 6.25% | 39.35% | 64.89% |
| Anuh Pharma | -0.78% | 1.72% | -3.90% | 1.15% | 0.25% | -10.86% |
| Bafna Pharma. | 4.99% | 18.04% | 14.91% | 112.57% | 166.33% | 188.09% |
Company Info
Company Information
Chairman / Executive Director / Managing Director : Surendra Somani
Independent Non Exe. Director : Chandresh Gandhi
Independent Non Exe. Director : Mamta Biyani
Independent Non Exe. Director : Narayan Atal
Non-Exec & Non-Independent Dir : Varun Somani
Non-Exec & Non-Independent Dir : Namrata Somani
Company Sec. & Compli. Officer : Sunil Sodhani